• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌缺血/再灌注损伤中的能量底物代谢和线粒体氧化应激。

Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury.

机构信息

Latvian Institute of Organic Synthesis, Riga, Latvia; Riga Stradins University, Riga, Latvia.

Amsterdam UMC, University of Amsterdam, Laboratory of Experimental Intensive Care and Anesthesiology, Department of Anesthesiology, Amsterdam Cardiovascular Sciences, Meibergdreef 9, AZ 1105, Amsterdam, the Netherlands.

出版信息

Free Radic Biol Med. 2021 Mar;165:24-37. doi: 10.1016/j.freeradbiomed.2021.01.036. Epub 2021 Jan 21.

DOI:10.1016/j.freeradbiomed.2021.01.036
PMID:33484825
Abstract

The heart is the most metabolically flexible organ with respect to the use of substrates available in different states of energy metabolism. Cardiac mitochondria sense substrate availability and ensure the efficiency of oxidative phosphorylation and heart function. Mitochondria also play a critical role in cardiac ischemia/reperfusion injury, during which they are directly involved in ROS-producing pathophysiological mechanisms. This review explores the mechanisms of ROS production within the energy metabolism pathways and focuses on the impact of different substrates. We describe the main metabolites accumulating during ischemia in the glucose, fatty acid, and Krebs cycle pathways. Hyperglycemia, often present in the acute stress condition of ischemia/reperfusion, increases cytosolic ROS concentrations through the activation of NADPH oxidase 2 and increases mitochondrial ROS through the metabolic overloading and decreased binding of hexokinase II to mitochondria. Fatty acid-linked ROS production is related to the increased fatty acid flux and corresponding accumulation of long-chain acylcarnitines. Succinate that accumulates during anoxia/ischemia is suggested to be the main source of ROS, and the role of itaconate as an inhibitor of succinate dehydrogenase is emerging. We discuss the strategies to modulate and counteract the accumulation of substrates that yield ROS and the therapeutic implications of this concept.

摘要

心脏是代谢灵活性最高的器官,可以根据不同能量代谢状态下可用的底物来使用。心脏线粒体可以感知底物的可用性,并确保氧化磷酸化和心脏功能的效率。线粒体在心肌缺血/再灌注损伤中也起着至关重要的作用,在此过程中,它们直接参与产生 ROS 的病理生理机制。本综述探讨了能量代谢途径中 ROS 产生的机制,并重点介绍了不同底物的影响。我们描述了在葡萄糖、脂肪酸和三羧酸循环途径中缺血期间积累的主要代谢物。高血糖症在缺血/再灌注的急性应激条件下很常见,它通过激活 NADPH 氧化酶 2 增加细胞浆 ROS 浓度,并通过代谢过载和减少己糖激酶 II 与线粒体的结合增加线粒体 ROS。脂肪酸相关的 ROS 产生与脂肪酸通量增加和相应的长链酰基辅酶 A 积累有关。在缺氧/缺血期间积累的琥珀酸被认为是 ROS 的主要来源,而衣康酸作为琥珀酸脱氢酶抑制剂的作用正在显现。我们讨论了调节和抵消产生 ROS 的底物积累的策略,以及这一概念的治疗意义。

相似文献

1
Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury.心肌缺血/再灌注损伤中的能量底物代谢和线粒体氧化应激。
Free Radic Biol Med. 2021 Mar;165:24-37. doi: 10.1016/j.freeradbiomed.2021.01.036. Epub 2021 Jan 21.
2
Increased Succinate Accumulation Induces ROS Generation in Ischemia/Reperfusion-Affected Rat Kidney Mitochondria.琥珀酸积累增加诱导缺血/再灌注损伤大鼠肾脏线粒体中 ROS 的产生。
Biomed Res Int. 2020 Oct 13;2020:8855585. doi: 10.1155/2020/8855585. eCollection 2020.
3
Inhibiting Succinate Release Worsens Cardiac Reperfusion Injury by Enhancing Mitochondrial Reactive Oxygen Species Generation.抑制琥珀酸释放通过增强线粒体活性氧物种生成加重心脏再灌注损伤。
J Am Heart Assoc. 2022 Jul 5;11(13):e026135. doi: 10.1161/JAHA.122.026135. Epub 2022 Jun 29.
4
Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS.琥珀酸的缺血性积累通过线粒体活性氧控制再灌注损伤。
Nature. 2014 Nov 20;515(7527):431-435. doi: 10.1038/nature13909. Epub 2014 Nov 5.
5
Oxidative stress precedes skeletal muscle mitochondrial dysfunction during experimental aortic cross-clamping but is not associated with early lung, heart, brain, liver, or kidney mitochondrial impairment.在实验性主动脉交叉钳夹过程中,氧化应激先于骨骼肌线粒体功能障碍出现,但与早期肺、心脏、脑、肝脏或肾脏线粒体损伤无关。
J Vasc Surg. 2014 Oct;60(4):1043-51.e5. doi: 10.1016/j.jvs.2013.07.100. Epub 2013 Oct 3.
6
The cardioprotective effects elicited by p66(Shc) ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury.p66(Shc)基因敲除所引发的心脏保护作用表明线粒体活性氧生成在缺血/再灌注损伤中起关键作用。
Biochim Biophys Acta. 2009 Jul;1787(7):774-80. doi: 10.1016/j.bbabio.2009.04.001. Epub 2009 Apr 9.
7
Mitochondrial network remodeling of the diabetic heart: implications to ischemia related cardiac dysfunction.糖尿病心脏中线粒体网络重构:对缺血相关心功能障碍的影响。
Cardiovasc Diabetol. 2024 Jul 18;23(1):261. doi: 10.1186/s12933-024-02357-1.
8
Reperfusion injury and reactive oxygen species: The evolution of a concept.再灌注损伤与活性氧:一个概念的演变
Redox Biol. 2015 Dec;6:524-551. doi: 10.1016/j.redox.2015.08.020. Epub 2015 Oct 8.
9
Cardioprotective effects of idebenone do not involve ROS scavenging: Evidence for mitochondrial complex I bypass in ischemia/reperfusion injury.依地醌的心脏保护作用不涉及 ROS 清除:在缺血/再灌注损伤中涉及线粒体复合物 I 旁路的证据。
J Mol Cell Cardiol. 2019 Oct;135:160-171. doi: 10.1016/j.yjmcc.2019.08.010. Epub 2019 Aug 22.
10
Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart.降低线粒体结合型己糖激酶II介导完整心脏从非损伤性缺血/再灌注向损伤性缺血/再灌注的转变。
J Physiol Biochem. 2016 Aug;73(3):323-333. doi: 10.1007/s13105-017-0555-3. Epub 2017 Mar 3.

引用本文的文献

1
SGLT2 Inhibitors: From Molecular Mechanisms to Clinical Outcomes in Cardiology and Diabetology.钠-葡萄糖协同转运蛋白2抑制剂:从分子机制到心脏病学和糖尿病学的临床结局
Molecules. 2025 Jul 25;30(15):3112. doi: 10.3390/molecules30153112.
2
Role of mitochondrial Ca in stroke: From molecular mechanism to treatment strategy (Review).线粒体钙在中风中的作用:从分子机制到治疗策略(综述)
Mol Med Rep. 2025 Oct;32(4). doi: 10.3892/mmr.2025.13636. Epub 2025 Aug 1.
3
Deletion of Skeletal Muscle Mitochondrial Glutamic-Oxaloacetic Transaminase (GOT2) Enhances Oxaloacetate Inhibition of Succinate Dehydrogenase and Alters Substrate Selectivity.
骨骼肌线粒体谷氨酸-草酰乙酸转氨酶(GOT2)的缺失增强了草酰乙酸对琥珀酸脱氢酶的抑制作用并改变了底物选择性。
FASEB J. 2025 Jul 31;39(14):e70825. doi: 10.1096/fj.202501071R.
4
The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection.先天性免疫受体NLRX1是线粒体通透性转换孔(mPTP)开放的新型必需调节因子:对心脏保护的意义。
Basic Res Cardiol. 2025 Jun 19. doi: 10.1007/s00395-025-01124-x.
5
The contribution of cardiomyocyte hypercontracture to the burden of acute myocardial infarction: an update.心肌细胞过度收缩对急性心肌梗死负担的影响:最新进展
Basic Res Cardiol. 2025 Jun 7. doi: 10.1007/s00395-025-01120-1.
6
Consensus classification of biliary complications after liver transplantation: guidelines from the BileducTx meeting.肝移植术后胆道并发症的共识分类:BileducTx会议指南
Br J Surg. 2025 Apr 30;112(5). doi: 10.1093/bjs/znae321.
7
Understanding Hypertension: A Metabolomic Perspective.从代谢组学角度理解高血压
Biology (Basel). 2025 Apr 11;14(4):403. doi: 10.3390/biology14040403.
8
Metabolic Adaptations and Therapies in Cardiac Hypoxia: Mechanisms and Clinical Implications/ Potential Strategies.心脏缺氧时的代谢适应与治疗:机制、临床意义及潜在策略
JACC Basic Transl Sci. 2025 Apr 2. doi: 10.1016/j.jacbts.2024.12.008.
9
Involvement of Oxidative Stress and Antioxidants in Modification of Cardiac Dysfunction Due to Ischemia-Reperfusion Injury.氧化应激和抗氧化剂在缺血再灌注损伤所致心脏功能障碍改变中的作用
Antioxidants (Basel). 2025 Mar 14;14(3):340. doi: 10.3390/antiox14030340.
10
Key Mechanisms of Oxidative Stress-Induced Ferroptosis in Heart Failure with Preserved Ejection Fraction and Potential Therapeutic Approaches.射血分数保留的心力衰竭中氧化应激诱导铁死亡的关键机制及潜在治疗方法。
Rev Cardiovasc Med. 2025 Mar 25;26(3):26613. doi: 10.31083/RCM26613. eCollection 2025 Mar.